The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study. (Q40669013)
Jump to navigation
Jump to search
scientific article published on 3 August 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study. |
scientific article published on 3 August 2015 |
Statements
The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study (English)
1 reference
Forouzan Faghihzadeh
Azita Hekmatdoost
3 August 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference